The Value of HPV-HR DNA Testing During the Follow-up After Treatment of CIN3/AIS

Overview

Journal Pathol Oncol Res

Specialty Oncology

Date 2014 Nov 30

PMID 25432549

Authors

Maja Banovic

Vesna Mahovlic

Kristina Meljanac Salopek

Vladimir Banovic

Ivan Babic

Slavko Oreskovic

Damir Babic

Affiliations

Soon will be listed here.

References

Katki H, Schiffman M, Castle P, Fetterman B, Poitras N, Lorey T . Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management. J Low Genit Tract Dis. 2013; 17(5 Suppl 1):S78-84. PMC: 3616418. DOI: 10.1097/LGT.0b013e31828543c5. View

Almog B, Gamzu R, Bornstein J, Levin I, Fainaru O, Niv J . Clinical and economic benefit of HPV-load testing in follow-up and management of women postcone biopsy for CIN2-3. Br J Cancer. 2003; 89(1):109-12. PMC: 2394203. DOI: 10.1038/sj.bjc.6601032. View

Zielinski G, Bais A, Helmerhorst T, Verheijen R, de Schipper F, Snijders P . HPV testing and monitoring of women after treatment of CIN 3: review of the literature and meta-analysis. Obstet Gynecol Surv. 2004; 59(7):543-53. DOI: 10.1097/00006254-200407000-00024. View

Gok M, Coupe V, Berkhof J, Verheijen R, Helmerhorst T, Hogewoning C . HPV16 and increased risk of recurrence after treatment for CIN. Gynecol Oncol. 2006; 104(2):273-5. DOI: 10.1016/j.ygyno.2006.10.011. View

Martin-Hirsch P, Paraskevaidis E, Kitchener H . Surgery for cervical intraepithelial neoplasia. Cochrane Database Syst Rev. 2000; (2):CD001318. DOI: 10.1002/14651858.CD001318. View

Prato B, Ghelardi A, Gadducci A, Marchetti I, Di Cristofano C, Di Coscio G . Correlation of recurrence rates and times with posttreatment human papillomavirus status in patients treated with loop electrosurgical excision procedure conization for cervical squamous intraepithelial lesions. Int J Gynecol Cancer. 2007; 18(1):90-4. DOI: 10.1111/j.1525-1438.2007.00965.x. View

Costa S, De Simone P, Venturoli S, Cricca M, Zerbini M, Musiani M . Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization. Gynecol Oncol. 2003; 90(2):358-65. DOI: 10.1016/s0090-8258(03)00268-3. View

Coupe V, Berkhof J, Verheijen R, Meijer C . Cost-effectiveness of human papillomavirus testing after treatment for cervical intraepithelial neoplasia. BJOG. 2007; 114(4):416-24. DOI: 10.1111/j.1471-0528.2007.01265.x. View

Arbyn M, Ronco G, Anttila A, Meijer C, Poljak M, Ogilvie G . Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine. 2012; 30 Suppl 5:F88-99. DOI: 10.1016/j.vaccine.2012.06.095. View

10.

Stanley M . Pathology and epidemiology of HPV infection in females. Gynecol Oncol. 2010; 117(2 Suppl):S5-10. DOI: 10.1016/j.ygyno.2010.01.024. View

11.

Bae J, Kim C, Park T, Namkoong S, Park J . Persistence of human papillomavirus as a predictor for treatment failure after loop electrosurgical excision procedure. Int J Gynecol Cancer. 2007; 17(6):1271-7. DOI: 10.1111/j.1525-1438.2007.00945.x. View

12.

Du R, Meng W, Chen Z, Zhang Y, Chen S, Ding Y . Post-treatment human papillomavirus status and recurrence rates in patients treated with loop electrosurgical excision procedure conization for cervical intraepithelial neoplasia. Eur J Gynaecol Oncol. 2014; 34(6):548-51. View

13.

Nuovo J, Melnikow J, Willan A, Chan B . Treatment outcomes for squamous intraepithelial lesions. Int J Gynaecol Obstet. 2000; 68(1):25-33. DOI: 10.1016/s0020-7292(99)00162-9. View